Cargando…
Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
Pathological cardiac hypertrophy induced by aging and neurohumoral activation, such as angiotensin II (Ang II) activation, is an independent risk factor for heart failure. The muscle really interesting new gene-finger protein-1 (MuRF1) and muscle atrophy F-box (MAFbx) pathway has been previously rep...
Autores principales: | Du, Fawang, Cao, Yalin, Ran, Yan, Wu, Qiang, Chen, Baolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438677/ https://www.ncbi.nlm.nih.gov/pubmed/34539827 http://dx.doi.org/10.3892/etm.2021.10665 |
Ejemplares similares
-
Muscle hypertrophy is associated with increases in proteasome activity that is independent of MuRF1 and MAFbx expression
por: Baehr, Leslie M., et al.
Publicado: (2014) -
Differences in the Role of HDACs 4 and 5 in the Modulation of Processes Regulating MAFbx and MuRF1 Expression during Muscle Unloading
por: Mochalova, Ekaterina P., et al.
Publicado: (2020) -
Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2
por: Witt, Christian C, et al.
Publicado: (2008) -
Rare Variants in Genes Encoding MuRF1 and MuRF2 Are Modifiers of Hypertrophic Cardiomyopathy
por: Su, Ming, et al.
Publicado: (2014) -
Small‐molecule‐mediated chemical knock‐down of MuRF1/MuRF2 and attenuation of diaphragm dysfunction in chronic heart failure
por: Adams, Volker, et al.
Publicado: (2019)